Literature DB >> 12109876

Molecular advances in understanding inherited prion diseases.

David R Brown1.   

Abstract

The prion diseases are neurodegenerative disorders that have attracted great interest because of the possible link between bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (CTD) in humans. Possible transmission of these diseases has been linked to a single protein termed the prion protein. This protein is an abnormal isoform of a normal synaptic glycoprotein. The majority of prion diseases does not appear to be caused by transmission of an infectious agent but occur spontaneously with no known cause. The strongest supporting evidence that the prion protein is the causative agent in prion disease comes from specific inheritable forms of prion disease which are linked to single point mutations in the prion protein gene. Paradoxically, these point mutations, although autosomal dominant with 100% penetrance do not lead to disease until late in life. Molecular techniques are now being used extensively to determine how these point-mutations alter the prion protein's normal structure and activity. This review deals with the latest insights into how inherited mutations in the prion protein gene lead to neurodegenerative disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12109876     DOI: 10.1385/MN:25:3:287

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  92 in total

1.  Prion proteins carrying pathogenic mutations are resistant to phospholipase cleavage of their glycolipid anchors.

Authors:  R Narwa; D A Harris
Journal:  Biochemistry       Date:  1999-07-06       Impact factor: 3.162

Review 2.  Inherited prion diseases and transmission to rodents.

Authors:  J Tateishi; T Kitamoto
Journal:  Brain Pathol       Date:  1995-01       Impact factor: 6.508

3.  Altered circadian activity rhythms and sleep in mice devoid of prion protein.

Authors:  I Tobler; S E Gaus; T Deboer; P Achermann; M Fischer; T Rülicke; M Moser; B Oesch; P A McBride; J C Manson
Journal:  Nature       Date:  1996-04-18       Impact factor: 49.962

4.  Familial prion disease mutation alters the secondary structure of recombinant mouse prion protein: implications for the mechanism of prion formation.

Authors:  R Cappai; L Stewart; M F Jobling; J M Thyer; A R White; K Beyreuther; S J Collins; C L Masters; C J Barrow
Journal:  Biochemistry       Date:  1999-03-16       Impact factor: 3.162

5.  The role of prion peptide structure and aggregation in toxicity and membrane binding.

Authors:  D L Rymer; T A Good
Journal:  J Neurochem       Date:  2000-12       Impact factor: 5.372

Review 6.  Prion diseases of humans and animals: their causes and molecular basis.

Authors:  J Collinge
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

7.  Mice devoid of PrP are resistant to scrapie.

Authors:  H Büeler; A Aguzzi; A Sailer; R A Greiner; P Autenried; M Aguet; C Weissmann
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

8.  Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein.

Authors:  H Büeler; M Fischer; Y Lang; H Bluethmann; H P Lipp; S J DeArmond; S B Prusiner; M Aguet; C Weissmann
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

9.  Normal host prion protein necessary for scrapie-induced neurotoxicity.

Authors:  S Brandner; S Isenmann; A Raeber; M Fischer; A Sailer; Y Kobayashi; S Marino; C Weissmann; A Aguzzi
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

10.  Experimental transmission of Creutzfeldt-Jakob disease and related diseases to rodents.

Authors:  J Tateishi; T Kitamoto; M Z Hoque; H Furukawa
Journal:  Neurology       Date:  1996-02       Impact factor: 9.910

View more
  1 in total

1.  Ancestral origins of the prion protein gene D178N mutation in the Basque Country.

Authors:  Ana B Rodríguez-Martínez; Christian Barreau; Isabelle Coupry; Jordi Yagüe; Raquel Sánchez-Valle; Luis Galdós-Alcelay; Agustín Ibáñez; Antón Digón; Ignacio Fernández-Manchola; Cyril Goizet; Azucena Castro; Nerea Cuevas; Maite Alvarez-Alvarez; Marian M de Pancorbo; Benoît Arveiler; Juan J Zarranz
Journal:  Hum Genet       Date:  2005-04-02       Impact factor: 4.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.